Active Recombinant Human IL2 protein

• Cat.No.: IL2-29H
• Product Overview: Recombinant Human IL2 was expressed in Insect Cells.

Specification

• Species: Human
• Source: Insect Cells
• Tag: Non
• Form: The protein was 0.22 µm filtered protein solution is in 10mM NaH2PO4, pH 7.2, 150mM NaCl at 0.2 mg/ml.
• Bio-activity: ED50 =0.5 - 2.0 ng/ml, corresponding to a specific activity of 0.5 - 2.0x10^6 units/mg, as determined by the dose dependent stimulation of CTLL2 cell proliferation..
• Molecular Mass: 15.5 kDa
• Endotoxin: < 1 EU/µg determined by LAL method.
• Purity: >95 % as determined by SDS-PAGE analysis
• Applications: Bioassay
• Storage: Unopened vial can be stored between 2°C and 8°C for three months, at -20°C for six months, or at -70°C for one year. For maximum results, quick spin vial prior to opening. Stock solutions should be prepared at no less than 10 µg/mL in buffer containing ca

Gene Information

• Gene Name: IL2 interleukin 2 [ Homo sapiens ]
• Official Symbol: IL2
• Synonyms: IL2; interleukin 2; interleukin-2; IL 2; T cell growth factor; TCGF; aldesleukin; involved in regulation of T-cell clonal expansion; IL-2; lymphokine
• Gene ID: 3558
• mRNA Refseq: NM_000586
• Protein Refseq: NP_000577
• MIM: 147680
• UniProt ID: P60568
• Chromosome Location: 4q26-q27
• Pathway: Allograft rejection, organism-specific biosystem; Allograft rejection, conserved biosystem; Autoimmune thyroid disease, organism-specific biosystem; Autoimmune thyroid disease, conserved biosystem; Calcineurin-regulated NFAT-dependent transcription in lymphocytes, organism-specific biosystem; Calcium signaling in the CD4+ TCR pathway, organism-specific biosystem; Chagas disease (American trypanosomiasis), organism-specific biosystem
• Function: carbohydrate binding; cytokine activity; glycosphingolipid binding; growth factor activity; interleukin-2 receptor binding; interleukin-2 receptor binding; kappa-type opioid receptor binding; kinase activator activity